This page is an unofficial LFoD record and is not legal advice. Verify the document against the official source before relying on it.
HB1747: relative to packaging of certain controlled drugs.
Bill details
Version history, amendments, and roll-call votes were not present in the imported local bill data.
Sponsors
- Vincent Paul Migliore House ยท Graf 9
Topics
Official links
HB 1747-FN - AS INTRODUCED
2018 SESSION
18-2400
01/04
HOUSE BILL 1747-FN
AN ACT relative to packaging of certain controlled drugs.
ANALYSIS
This bill requires manufacturers to pre-package class II controlled drugs which are going to be dispensed in New Hampshire in blister packs with serial numbers on each pill.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
18-2400
01/04
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Eighteen
AN ACT relative to packaging of certain controlled drugs.
Be it Enacted by the Senate and House of Representatives in General Court convened:
1 New Section; Packaging of Class II Controlled Drugs. Amend RSA 318-B by inserting after section 9 the following new section:
318-B:9-a Packaging of Class II Controlled Drugs. Manufacturers packaging class II controlled drugs to be dispensed in New Hampshire shall pre-package such drugs in individual dose blister packs with traceable inventory serial numbers on each pill.
2 Effective Date. This act shall take effect January 1, 2019.
LBAO
18-2400
11/17/17
HB 1747-FN- FISCAL NOTE
AS INTRODUCED
AN ACT relative to packaging of certain controlled drugs.
FISCAL IMPACT: [ X ] State [ ] County [ ] Local [ ] None
Estimated Increase / (Decrease)
STATE:
FY 2019
FY 2020
FY 2021
FY 2022
Appropriation
$0
$0
$0
$0
Revenue
Indeterminable Increase
Indeterminable Increase
Indeterminable Increase
Indeterminable Increase
Expenditures
Indeterminable Increase
Indeterminable Increase
Indeterminable Increase
Indeterminable Increase
Funding Source:
[ X ] General [ ] Education [ ] Highway [ X ] Other - Federal Medicaid Revenue
METHODOLOGY:
The Department of Health and Human Services assumes implementation of the packaging and tracking requirements in New Hampshire could cause some manufacturers to cease distributing class II drugs in New Hampshire or increase their prices to cover the additional packaging, tracking and distribution costs. The increase in costs to the Medicaid program for class II controlled drugs cannot be determined. Medicaid expenditures are paid with a combination of state and federal funds, therefore any increase in Medicaid expenditures will also increase federal restricted revenue by 50% of the expenditure increase.
The Office of Professional Licensure and Certification states this bill would have no fiscal impact on the Office or on the Board of Pharmacy.
AGENCIES CONTACTED:
Department of Health and Human Services and Office of Professional Licensure and Certification